Ozempic Vision Loss Lawsuits: Has Your Eyesight Been Damaged?

Ozempic, Wegovy, and Zepbound may cause sudden or permanent blindness. If you or a loved one suffered vision loss, you may qualify.

Quick Facts About Ozempic Vision Loss and GLP-1 Drugs

Ozempic and similar GLP-1 medications have been widely prescribed for type 2 diabetes and weight loss – but recent studies now link them to permanent vision damage and have led to a growing number of Ozempic vision loss lawsuits.

  • Drug Class: GLP-1 receptor agonists (includes Ozempic, Wegovy, Zepbound, Mounjaro)
  • Common Uses: Blood sugar control and off-label weight loss treatment
  • Vision Injury Risk: New research shows increased risk of vision loss, including optic neuropathy and retinal damage. Read research
  • Related Injuries: Sudden blindness, blurry or dim vision, difficulty focusing

start my Ozempic free CASE REVIEW

CALL NOW:  1-866-374-0338

Do You Qualify for an Ozempic Vision Loss Lawsuit or Settlement?

Medical Criteria

Most eligible claimants meet one or more of the following:

  • Took a GLP-1 receptor agonist such as Ozempic, Wegovy, Zepbound, or Mounjaro for diabetes or weight loss
  • Developed vision loss, optic neuropathy, blurry vision, or blindness
  • Symptoms began during or shortly after GLP-1 drug use
  • No pre-existing eye condition that fully explains the symptoms
  • Willing to provide pharmacy records and diagnostic eye exams

Preferred Documentation

If you don’t yet have these, our team can help you secure them

  • Prescription records showing GLP-1 drug use
  • Notes or reports from an ophthalmologist or optometrist
  • Retinal imaging or optic nerve scans (OCT, visual field tests, etc.)
  • Timeline or journal noting when symptoms began
  • Emergency room visits or hospitalization records related to vision

We offer a free, no-obligation case review.
You don’t need to have every document in hand – we’ll help you gather what’s needed to pursue your Ozempic vision loss lawsuit.
Get a free Ozempic vision loss lawsuit case review →

Signs of Ozempic-Linked Vision Damage

Patients taking Ozempic, Wegovy, or Zepbound have reported the following vision loss symptoms tied to optic nerve damage.

Respiratory depression
Sudden vision loss in one eye
Loss of conciousness
Blurred or cloudy vision
Severe Sedation
Dark spots or shadows in vision
Confusion or disorientation
Loss of peripheral vision
Nausea or vomiting
Color vision problems
Skin irritation or burns
Light sensitivity (photophobia)
Not sure? Get a free case review →

ALERT: Act quickly – many patients don’t realize their vision problems may be linked to GLP-1 drugs like Ozempic until it’s too late.

Ozempic Vision Loss MDL Timeline

The lawsuits over Ozempic and similar GLP-1 drugs are gaining national momentum. Here’s how the MDL has progressed:

Jul 2024

July 2024 – Harvard Study Finds 8x Higher Risk of NAION

A pivotal study published in JAMA Ophthalmology found that patients taking semaglutide (Ozempic, Wegovy) were up to 8 times more likely to develop nonarteritic anterior ischemic optic neuropathy (NAION), a condition that can cause sudden, irreversible blindness. Read the Harvard-led JAMA Ophthalmology Study
FEB 2024

February 2, 2024 – MDL 3094 Formed

The U.S. Judicial Panel on Multidistrict Litigation centralized all federal lawsuits involving GLP-1 receptor agonists – including Ozempic, Wegovy, Trulicity, Rybelsus, and Mounjaro – into MDL No. 3094 in the Eastern District of Pennsylvania.
AUG 2024

August 2024 – Master Complaint Filed

Plaintiffs filed a consolidated Master Complaint outlining key allegations: failure to warn, design defects, and serious injuries – now officially including optic nerve damage and vision loss tied to GLP‑1 use (Ozempic, Wegovy).
JUN 2025

JUNE 2025 – Bellwether Process Begins

The court begins selecting representative cases to go to trial first. Plaintiffs with blindness or NAION may be among the early bellwether candidates.

Vision Loss After Ozempic or Wegovy?

Get answers. Get help. Start your free vision loss case review today.

Call Now!
1-866-374-0338

or

Get Started!
Request a callback online

With over 30 years of experience and more than $100 million recovered, The Johnson Law Firm has stood up to major drug manufacturers and won. We’re proud to represent clients across the U.S. in high-stakes litigation involving defective medications.

Real Results From Real Clients

“I was scared before I hired The Johnson Law Firm. They fought for me – and I was overwhelmed with the result. I received half a million dollars.”
— Nina S.

Doctor reviewing medical chart with patient during Ozempic vision loss lawsuit consultation

How an Ozempic Vision Loss Lawsuit Works

Lawsuits over Ozempic and other GLP-1 drugs are now consolidated in MDL No. 3094, a federal multidistrict litigation based in the Eastern District of Pennsylvania. If you or a loved one suffered sudden or permanent vision loss after using Ozempic, Wegovy, or similar medications, here’s what to expect:

  • Early Signal Detection: Patient reports of sudden vision loss, optic nerve damage, and blindness led to investigations and safety alerts, prompting legal action.
  • Case Consolidation: Hundreds of individual lawsuits are now being processed together under MDL 3094, streamlining discovery, expert evaluation, and pretrial motions.
  • Causation Proof: Medical experts – including ophthalmologists and neurologists—testify about the connection between GLP-1 receptor agonists and optic neuropathy or NAION (a serious, irreversible eye condition).
  • Core Legal Allegations:
  • Failure to Warn: Drugmakers failed to alert users about potential vision risks.
  • Negligent Marketing: Risks may have been downplayed or omitted in consumer materials.
  • Defective Design: Some claims allege the drug’s mechanism could trigger vision damage in susceptible patients.
  • Compensation: If successful, plaintiffs may be entitled to financial compensation covering a range of damages. This includes medical costs related to eye treatments or surgeries, loss of income due to vision impairment, pain and suffering, emotional distress, and any permanent loss of vision that impacts daily life or earning ability.
  • Settlement vs. Trial: Most lawsuits in MDLs result in confidential settlements. However, bellwether trials beginning in 2025 may set precedent and shape payouts.
  • Contingency-Fee Promise: Our firm handles these cases on a contingency-fee basis – you pay nothing unless we win compensation for you.

Results-Driven Representation: Our team will marshal the latest science, review your medical records at no cost, and fight for the maximum compensation you deserve.

Our Ozempic Vision Loss Lawsuit Process

At The Johnson Law Firm, we’re committed to guiding you through every step of your Ozempic or GLP-1 vision loss claim – using our experience with complex drug litigation, expert partnerships, and aggressive legal strategy to help you pursue the compensation you deserve.

Here’s how the process works:

  • Free Case Evaluation: We’ll review your medical history, pharmacy records, and vision-related symptoms — at no cost — to determine if you may qualify for an Ozempic vision loss claim.
  • Medical Expert Support: Our legal team collaborates with ophthalmologists, neurologists, and GLP-1 research experts to evaluate evidence of optic nerve damage or sudden blindness linked to these medications.
  • Regulatory & Scientific Review: We examine FDA safety data, adverse event reports, and recent clinical research (including Harvard’s NAION study) to build a strong foundation for your case.
  • MDL Participation: If your case is eligible, we’ll consider filing it in file it in either MDL No. 3094, the federal multidistrict litigation centralized in the Eastern District of Pennsylvania or another appropriate court – streamlining the legal process and improving your chances of meaningful compensation.
  • No Fees Unless We Win: We work on a contingency-fee basis – you pay nothing unless we successfully recover money for your medical bills, vision-related losses, and suffering.

Results-Driven Representation: Focus on your health while we fight for maximum recovery.

Ozempic Vision Loss Lawsuit FAQs

You may be eligible if you took Ozempic, Wegovy, Zepbound, or Mounjaro and later experienced vision loss, optic nerve damage (such as NAION), blurry vision, or blindness – especially if symptoms began during or shortly after use.

Drugmakers are accused of failing to adequately warn patients and doctors about the risk of serious eye injuries such as nonarteritic anterior ischemic optic neuropathy (NAION), which may result in sudden, irreversible vision loss.

Yes. A 2024 Harvard-led study published in JAMA Ophthalmology found that users of semaglutide (Ozempic, Wegovy) were up to 8 times more likely to develop NAION, a leading cause of sudden blindness. This research is central to current legal claims.

Multidistrict Litigation (MDL) No. 3094 consolidates all federal lawsuits involving GLP-1 drugs (like Ozempic, Wegovy, and Mounjaro) into one court in the Eastern District of Pennsylvania, streamlining the process for discovery, motions, and bellwether trials.

Compensation may include payment for medical costs, lost wages, loss of future earnings, vision-related disability, emotional distress, and pain and suffering. Some cases may also seek punitive damages.

There are no upfront costs. Our firm works on a contingency-fee basis – you pay nothing unless we recover money for you.

Deadlines vary by state, but time is limited. If you suspect your vision loss is connected to a GLP-1 drug, it’s important to act quickly to preserve your rights and evidence.

Ready for Your Free Ozempic Vision Loss Case Review?

Our legal team is currently accepting claims related to Ozempic, Wegovy, and other GLP-1 drugs causing vision loss or blindness.

Trusted nationwide. Thousands of clients. Millions recovered. No fees unless we win.

Ribbon Award Icon

35+ Years of Experience

Since 1993, trusted nationwide
Ribbon Award Icon

$100M+ Recovered to Clients

Product liability & mass torts
Ribbon Award Icon

No Fees Unless We Win

You pay nothing upfront
Ribbon Award Icon

Nationwide Representation

Clients in all 50 states